vs
Side-by-side financial comparison of AGENUS INC (AGEN) and LCNB CORP (LCNB). Click either name above to swap in a different company.
AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $23.9M, roughly 1.4× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -31.0%, a 54.7% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs 5.1%). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs 10.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
AGEN vs LCNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $23.9M |
| Net Profit | $-10.6M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | 42.1% | 29.2% |
| Net Margin | -31.0% | 23.7% |
| Revenue YoY | 27.5% | 5.1% |
| Net Profit YoY | 77.3% | -7.6% |
| EPS (diluted) | $0.09 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.2M | $23.9M | ||
| Q3 25 | $30.2M | $23.8M | ||
| Q2 25 | $25.7M | $22.8M | ||
| Q1 25 | $24.1M | $21.5M | ||
| Q4 24 | $26.8M | $22.7M | ||
| Q3 24 | $25.1M | $21.4M | ||
| Q2 24 | $23.5M | $19.3M | ||
| Q1 24 | $28.0M | $17.8M |
| Q4 25 | $-10.6M | $5.7M | ||
| Q3 25 | $63.9M | $6.9M | ||
| Q2 25 | $-30.0M | $5.9M | ||
| Q1 25 | $-26.4M | $4.6M | ||
| Q4 24 | $-46.8M | $6.1M | ||
| Q3 24 | $-67.2M | $4.5M | ||
| Q2 24 | $-54.8M | $925.0K | ||
| Q1 24 | $-63.5M | $1.9M |
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — | ||
| Q1 24 | 99.6% | — |
| Q4 25 | 42.1% | 29.2% | ||
| Q3 25 | -15.0% | 35.6% | ||
| Q2 25 | -65.0% | 31.6% | ||
| Q1 25 | -55.3% | 25.6% | ||
| Q4 24 | -96.5% | 32.9% | ||
| Q3 24 | -125.5% | 24.9% | ||
| Q2 24 | -128.4% | 4.9% | ||
| Q1 24 | -117.4% | 12.5% |
| Q4 25 | -31.0% | 23.7% | ||
| Q3 25 | 211.4% | 29.1% | ||
| Q2 25 | -116.8% | 26.0% | ||
| Q1 25 | -109.6% | 21.4% | ||
| Q4 24 | -174.4% | 27.0% | ||
| Q3 24 | -267.7% | 21.2% | ||
| Q2 24 | -233.1% | 4.8% | ||
| Q1 24 | -226.6% | 10.7% |
| Q4 25 | $0.09 | $0.40 | ||
| Q3 25 | $1.94 | $0.49 | ||
| Q2 25 | $-1.00 | $0.41 | ||
| Q1 25 | $-1.03 | $0.33 | ||
| Q4 24 | $-1.95 | $0.44 | ||
| Q3 24 | $-3.08 | $0.31 | ||
| Q2 24 | $-2.52 | $0.07 | ||
| Q1 24 | $-3.04 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $21.6M |
| Total DebtLower is stronger | $44.7M | $104.4M |
| Stockholders' EquityBook value | $-271.1M | $273.9M |
| Total Assets | $226.8M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $21.6M | ||
| Q3 25 | $3.5M | $35.9M | ||
| Q2 25 | $9.5M | $49.8M | ||
| Q1 25 | $18.5M | $37.7M | ||
| Q4 24 | $40.4M | $35.7M | ||
| Q3 24 | $44.8M | $39.4M | ||
| Q2 24 | $93.7M | $34.9M | ||
| Q1 24 | $52.9M | $33.0M |
| Q4 25 | $44.7M | $104.4M | ||
| Q3 25 | $34.2M | $104.7M | ||
| Q2 25 | $33.9M | $105.0M | ||
| Q1 25 | $33.6M | $104.6M | ||
| Q4 24 | $33.2M | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $-271.1M | $273.9M | ||
| Q3 25 | $-274.1M | $269.9M | ||
| Q2 25 | $-354.6M | $263.5M | ||
| Q1 25 | $-341.8M | $258.7M | ||
| Q4 24 | $-326.4M | $253.0M | ||
| Q3 24 | $-292.3M | $253.2M | ||
| Q2 24 | $-241.3M | $245.2M | ||
| Q1 24 | $-201.4M | $233.7M |
| Q4 25 | $226.8M | $2.2B | ||
| Q3 25 | $233.9M | $2.2B | ||
| Q2 25 | $185.2M | $2.3B | ||
| Q1 25 | $200.2M | $2.3B | ||
| Q4 24 | $226.3M | $2.3B | ||
| Q3 24 | $238.5M | $2.3B | ||
| Q2 24 | $292.4M | $2.4B | ||
| Q1 24 | $256.6M | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | $34.4M |
| Free Cash FlowOCF − Capex | — | $33.4M |
| FCF MarginFCF / Revenue | — | 140.2% |
| Capex IntensityCapex / Revenue | 0.0% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.6M | $34.4M | ||
| Q3 25 | $-14.7M | $14.0M | ||
| Q2 25 | $-20.2M | $5.5M | ||
| Q1 25 | $-25.6M | $2.2M | ||
| Q4 24 | $-28.7M | $93.2M | ||
| Q3 24 | $-53.3M | $11.9M | ||
| Q2 24 | $-38.2M | $54.9M | ||
| Q1 24 | $-38.2M | $-11.9M |
| Q4 25 | — | $33.4M | ||
| Q3 25 | — | $13.7M | ||
| Q2 25 | $-20.2M | $5.2M | ||
| Q1 25 | $-25.6M | $2.1M | ||
| Q4 24 | $-28.7M | $89.4M | ||
| Q3 24 | $-53.3M | $10.5M | ||
| Q2 24 | $-38.6M | $53.8M | ||
| Q1 24 | $-38.2M | $-12.8M |
| Q4 25 | — | 140.2% | ||
| Q3 25 | — | 57.4% | ||
| Q2 25 | -78.7% | 23.0% | ||
| Q1 25 | -106.5% | 10.0% | ||
| Q4 24 | -107.0% | 394.0% | ||
| Q3 24 | -212.2% | 49.0% | ||
| Q2 24 | -164.4% | 278.6% | ||
| Q1 24 | -136.5% | -71.8% |
| Q4 25 | 0.0% | 4.0% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.3% | 16.7% | ||
| Q3 24 | 0.0% | 6.7% | ||
| Q2 24 | 2.0% | 5.9% | ||
| Q1 24 | 0.1% | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | -0.23× | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
LCNB
Segment breakdown not available.
